微门户首页  新闻  讨论区  活动  博客  求职招聘  行业报告  圈内成员  供应   
已读[230] 发布: 2013/07/03 14:58:28
各种自身免疫病的治疗,如类风湿性关节炎、系统性红斑狼疮、干燥综合症等。初步药代动力学表明,PEG修饰,半衰期明显延长。已完成中试工艺和质量研究。...
已读[134] 发布: 2013/06/23 12:47:46
采访中记者了解到,在科技人才队伍的带领下,目前恩度持续开发项目的任务之一,聚乙二醇(PEG)化恩度已于2011年向国家食品药品监督管理局申请临床研究,其他项目正处于临床前研究阶段。据悉,项目顺利完成后,...
已读[139] 发布: 2013/06/23 12:47:39
...目前,乙肝治疗新药物研发进展缓慢,根据患者个体需求调整综合治疗方案成为业内专家共识。但是由于慢性乙肝患者类型复杂,对于一些药物比如聚乙二醇干扰素,在临床上如何确定不同患者使用的时机、方案,判断疗效以及治疗终点等问题,还没有大规模临床研究形成推荐意见,有待进一步探索。
已读[189] 发布: 2013/06/23 12:47:35
色谱条件与系统适用性试验:以聚乙二醇(PEG)-20M为固定相,涂布浓度为20%;柱温90℃。理论板数按α-蒎烯峰计算应不低于1500。 校正因子测定:取正丁醇适量,精密称定,加石油醚(30~60℃)溶解并稀释成每1ml含20mg的溶液,作为内标溶液。另取α-蒎烯对照品约30mg,精密称定,...
已读[133] 发布: 2013/06/23 12:47:32
...温和不刺激肌肤,让肌肤具有极佳的亲和性;另外,透明质酸和多元醇既保证了高效天然的保湿功能和温和安全性,又保证了产品的稳定性能,解决了酒精和聚乙二醇所产生的刺激肌肤等诸多负面因素。 ...
已读[122] 发布: 2013/06/23 12:47:25
plastemart.com As Chinese produces cut PET offers to reduce inventories, Asian polyethylene terephthalate (PET) production margin flipped to negative territory early Wednesday. This is for the first time since the Asian close on April 17 that ... This calculation ...
已读[122] 发布: 2013/06/23 12:47:12
In-PharmaTechnologist.com The pegylation platform is used to add polyethylene glycol ( PEG ) to drug molecules, thereby modifying their physical characteristics and making them easier to deliver according to Belrose CEO Eric Gilbert who told in-Pharmatechnologist.com about the deal.
已读[679] 发布: 2013/06/23 12:47:08
ICIS (subscription) An estimated cost advantage of $350/tonne shows why these regions are also becoming main producers of basic organic chemicals such as polyethylene (PE), polypropylene (PP) and ethylene glycol (EG). STEADY BASICS The VCI said that Germany  ...
已读[114] 发布: 2013/06/23 12:47:05
PR Newswire (press release) Through this transaction, Belrose Pharma has added to its portfolio both "traditional" permanent PEGylation and the lesser-known releasable P...
已读[113] 发布: 2013/06/23 12:47:02
News-Medical.net IG-004 (TOCOSOL® paclitaxel) is a tocopheryl polyethylene glycol succinate (TPGS)-based emulsion of paclitaxel. IG-004 has completed Phase 2 or 3 trials in MBC, NSCLC, ovarian cancer, colorectal cancer and bladder cancer in the U.S. and/or ex-U.S. The  ... 更多 »
« 上一页  |   查看结果141-150共494   |  下一页 »

新闻标签:

没有标签


最新报告


求职招聘